Skip to content

Beyfortus (nirsevimab) Effectiveness Against RSV Medically-Attended Events in Infants (BEAR Study)

This study will estimate the effectiveness of Beyfortus (nirsevimab) against PCR-confirmed RSV with a lower respiratory tract disease diagnosis & to estimate the effectiveness of nirsevimab against medical encounters for PCR-confirmed RSV with lower respiratory tract disease.

Investigator: Klein, Nicola

Funder: Sanofi

Explore all studies and publications

Back To Top